Ignite Creation Date:
2024-05-05 @ 12:00 PM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00206726
Status:
COMPLETED
Last Update Posted:
2016-08-29
First Post:
2005-09-19
Brief Title:
AlemtuzumabFludarabine for RelapsedRefractory B-cell Chronic Lymphocytic Leukemia B-CLL
Sponsor:
Organization:
Sanofi